Disclaimer

This website is not a prospectus, circular, advertisement or representation intended for use in the purchase or sale of any security or other financial products. In addition, the information contained herein does not convey an offer of any type and is neither intended to be nor should be construed as an offer to sell, or the solicitation of an offer to buy, any securities or other financial products. An offer to invest in an interest in a fund will be made only to qualified investors by means of the confidential offering memorandum and subscription documents of such fund to be furnished at a later date and will be made only in those jurisdictions where permitted by law. Any discussion of any strategy or risks relating to an investment in a fund is qualified in its entirety by the reference to such fund’s confidential offering memorandum. Past performance is not indicative of future results and there is no guarantee that any fund will meet its investment objective or be profitable. The information provided on this website does not necessarily reflect the most up-to-date information available for a fund. Nothing herein is intended as investment, legal, tax or similar advice. Individuals should consult with their own investment, legal, tax and/or similar professionals regarding their specific situations.

Investing in securities and other instruments of healthcare companies involves substantial risks, including (but not limited to) the following: certain companies may have limited operating histories; scarcity of management and marketing personnel with appropriate scientific or medical training may slow or impede companies’ growth; the possibility of lawsuits related to patents or products; obsolescence of products; change in government policies; changing investor sentiments and preferences with regard to healthcare sector investments (some of which are generally perceived as risky) may have an adverse effect on the price of underlying securities; volatility in the stock markets affecting the prices of healthcare company securities may cause the performance of a fund to experience substantial volatility; and many companies in the healthcare sector are subject to extensive government regulation. Healthcare and life sciences related companies are generally subject to greater governmental regulation than other industries at both the state and federal levels. Changes in governmental policies may have a material effect on the demand for or costs of certain products and services. In addition, obtaining approval for new products from governmental agencies can be lengthy, expensive and uncertain. Any failure to obtain approval or other negative assessment for new or existing products from governmental agencies can result in significant decreases in the prices of the subject healthcare company securities, or even in the securities of related healthcare companies, which may cause a loss for a fund.

The interests in a fund may not be eligible for sale in some states or countries, or suitable for all types of investors. Prospective investors should inform themselves as to the legal requirements and tax consequences regarding an investment in the Fund within the countries of their citizenship, residence, domicile and place of business. Additional information may be available upon request. None of the information contained herein has been filed with the U.S. Securities and Exchange Commission, any securities administrator under any securities laws of any U.S. or non-U.S. jurisdiction or any other U.S. or non-U.S. governmental or self-regulatory authority. No such governmental or self-regulatory authority will pass on the merits of the offering of a fund, or the adequacy of the information contained herein. Any representation to the contrary is unlawful.